KEI Work on CRISPR and CRISPR-related Inventions

You also can search for our most recent work on clustered regularly interspaced short palindromic repeats (CRISPR) technologies using our tags here, or via our general search engine here.

KEI Events regarding CRISPR

• 2019: Expert Workshop at Brocher Foundation- An Examination of the Ethical, Legal and Social Implications of the WTO TRIPS Agreement on access to gene and cell-based treatments including CAR T and CRISPR (Agenda; List of Participants)
• 2019: Expert Panel – Assessing the implications of the development of new cell and gene-based therapies (including CAR T and CRISPR): What role should WHO play?
• 2018: Panel Discussion: the Implications of Article 27.3(a) of the WTO TRIPS Agreement on the patentability of gene and cell-based therapies
• 2017 Workshop: Patents, the Public Interest and Two New Medical Technologies: CRISPR and CAR T

CRISPR-related NIH Exclusive Licenses

• 2019: KEI and UACT comment on NIH license to Tailored Therapeutics for the development and commercialization of cell therapies for cancer

KEI Blogs related to CRISPR

• 2017: KEI asks the Department of Health and Human Services to adopt a policy on licensing CRISPR patents
• 2017: NIH response to KEI request for NIH policy on on the licensing of federally-funded CRISPR patented inventions
• 2017: All 12 Zhang/Broad Institute CRISPR patents declare US funding and rights in inventions